Establishment of stromal cell line from an MDS RA patient which induced an apoptopic change in hematopoietic and leukemic cells in vitro

被引:15
作者
Aizawa, S
Hiramoto, M
Hoshi, H
Toyama, K
Shima, D
Handa, H
机构
[1] Nihon Univ, Sch Med, Dept Anat, Itabashi Ku, Tokyo 1738610, Japan
[2] Tokyo Med Coll, Dept Internal Med, Tokyo 160, Japan
[3] Tokyo Inst Technol, Fac Biosci & Technol, Dept Biomol Engn, Tokyo 152, Japan
关键词
myelodysplastic syndrome; bone marrow stromal cell; apoptosis; CD34-positive cell; leukemia; recombinant SV40-adenovirus vector;
D O I
10.1016/S0301-472X(99)00142-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. We previously reported on the heterogeneity of bone marrow stromal cell function in supporting hematopoietic cell proliferation and differentiation in vitro among refractory anemia (RA) of myelodysplastic syndrome (RIDS) patients. Interestingly, stromal cells from some MDS RA patients induced an apoptotic change in CD34(+) hematopoietic cells. However, the mechanism responsible for this action was unclear. Materials and Methods. In the present study, we established a cloned stromal cell line (LS801) from an MDS RA patient by introducing recombinant SV40-adenovirus vector containing the SV40 early gene. Results. LS801 induced an apoptotic change in CD34(-) cells from normal subjects and cloned leukemic cells in a coculture system. When hematopoietic cells were cocultured but kept separate from LS801 by a 0.45-mu m Millipore membrane to prevent their attachment, the action of LS801 in inducing apoptosis of hematopoietic cells was inhibited. Additionally, no production of fas ligand, tumor necrosis factor a or interferon gamma in LS801 was observed. Conclusion. These findings suggest that the novel stromal cell line LS801 will shed light on research into the mechanism underlying the apoptotic changes induced by stromal cells in hematopoietic cells, (C) 2000 International Society for Experimental Hematology. Published by Elsevier Science Inc.
引用
收藏
页码:148 / 155
页数:8
相关论文
共 31 条
[1]   Bone marrow stroma from refractory anemia of myelodysplastic syndrome is defective in its ability to support normal CD34-positive cell proliferation and differentiation in vitro [J].
Aizawa, S ;
Nakano, M ;
Iwase, O ;
Yaguchi, M ;
Hiramoto, M ;
Hoshi, H ;
Nabeshima, R ;
Shima, D ;
Handa, H ;
Toyama, K .
LEUKEMIA RESEARCH, 1999, 23 (03) :239-246
[2]  
AIZAWA S, 1994, EXP HEMATOL, V22, P482
[3]  
Aizawa S, 1997, ACTA HAEMATOL-BASEL, V98, P140
[4]   ESTABLISHMENT OF A VARIETY OF HUMAN BONE-MARROW STROMAL CELL-LINES BY THE RECOMBINANT SV40-ADENOVIRUS VECTOR [J].
AIZAWA, S ;
YAGUCHI, M ;
NAKANO, M ;
INOKUCHI, S ;
HANDA, H ;
TOYAMA, K .
JOURNAL OF CELLULAR PHYSIOLOGY, 1991, 148 (02) :245-251
[5]   Stem cell factor enhances the adhesion of AML cells to fibronectin and augments fibronectin-mediated anti-apoptotic and proliferative signals [J].
Bendall, LJ ;
Makrynikola, V ;
Hutchinson, A ;
Bianchi, AC ;
Bradstock, KF ;
Gottlieb, DJ .
LEUKEMIA, 1998, 12 (09) :1375-1382
[6]  
BENDALL LJ, 1994, EXP HEMATOL, V22, P1252
[7]  
Campana D, 1996, Hum Cell, V9, P317
[8]  
CHUI DHK, 1982, BLOOD, V60, P362
[9]   FUNCTIONAL-STUDIES OF BONE-MARROW HEMATOPOIETIC AND STROMAL CELLS IN THE MYELODYSPLASTIC SYNDROME (MDS) [J].
COUTINHO, LH ;
GEARY, CG ;
CHANG, J ;
HARRISON, C ;
TESTA, NG .
BRITISH JOURNAL OF HAEMATOLOGY, 1990, 75 (01) :16-25
[10]   CONDITIONS CONTROLLING PROLIFERATION OF HEMATOPOIETIC STEM-CELLS INVITRO [J].
DEXTER, TM ;
ALLEN, TD ;
LAJTHA, LG .
JOURNAL OF CELLULAR PHYSIOLOGY, 1977, 91 (03) :335-344